SCHEMBL9916163

SCHEMBL9916163

CC(C)c1ccc(-c2ccc3c(c2)oc2cc(-c4ccccc4)ccc23)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 1/20 0.48
PARP1 P09874 1/20 0.48
TNKS2 Q9H2K2 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
PARP2 Q9UGN5 1/20 0.48
PTPN5 P54829 1/20 0.42
MMP12 P39900 1/20 0.42
MMP13 P45452 1/20 0.42
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
RXRG P48443 1/20 0.41
PTGS2 P35354 1/20 0.41
AHR P35869 1/20 0.41
BCHE P06276 4/20 0.40
ACHE P22303 4/20 0.40
PRKDC P78527 1/20 0.40
GAA P10253 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9916189 1.00 TNKS (0.48) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL9916160 0.95 RXRA (0.44) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL9916153 0.92 TNKS (0.57) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL9916205 0.92 TNKS (0.57) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL9916179 0.92 TNKS (0.57) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL24502101 0.91 TNKS (0.43) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL9916176 0.91 TNKS (0.54) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL9916207 0.91 TNKS (0.54) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL9916190 0.91 TNKS (0.54) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL9916196 0.91 TNKS (0.54) TNKSPARP1TNKS2HDAC6PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170162790-A1 AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2017-06-08 US disclosed
US-9614160-B2 Aromatic amine derivatives and organic electroluminescent elements using same IDEMITSU KOSAN CO., LTD. (JP) 2017-04-04 US disclosed
US-9614160-B2 Aromatic amine derivatives and organic electroluminescent elements using same IDEMITSU KOSAN CO., LTD. (JP) 2017-04-04 US disclosed
US-20160064669-A1 AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-03-03 US disclosed
US-9260390-B2 Aromatic amine derivatives and organic electroluminescent elements using same IDEMITSU KOSAN CO., LTD. (JP) 2016-02-16 US disclosed
US-20120146014-A1 AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-06-14 US disclosed
US-20120146014-A1 AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170162790-A1 AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME RER1, NR4A1, REL TNKS 4121/4885PARP1 2443/4885TNKS2 4382/4885
US-20120146014-A1 AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME PNMT, TYR, AOC2 TNKS 3400/4885PARP1 2473/4885TNKS2 3512/4885
US-20160064669-A1 AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME PNMT, TYR, AOC2 TNKS 3400/4885PARP1 2473/4885TNKS2 3512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.